New Owner
GSK (GlaxoSmithKline) - Sirtris Pharmaceuticals
GSK (GlaxoSmithKline) acquires Sirtris Pharmaceuticals
Announced: April 22, 2008
Type: Acquisition
Disposition: Combined
Terms: Cash
Status: Complete
Amount: $ 720,000,000
GSK (GlaxoSmithKline) Other Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| May 29, 2013 |
|
$ 325,000,000 |
| Aug 03, 2012 |
|
$ 3,000,000,000 |
| May 15, 2012 |
|
£ 61,000,000 |
| Jun 09, 2010 |
|
$ 253,000,000 |
| May 24, 2010 |
|
$ 135,000,000 |
| Apr 20, 2009 |
|
Undisclosed amount |
